CRMD FY 2021 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena

CRMDCorMedix Inc.

$536M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$190,936-20.2% YoY

Gross Profit

$41,99822.0% margin

Operating Income

-$29M-15417.5% margin

Net Income

-$28M-14774.7% margin

EPS (Diluted)

$-0.75

Cash Flow

Operating Cash Flow

-$21M

Free Cash Flow

-$23M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$69M

Total Liabilities

$6M

Stockholders' Equity

$63M

Cash & Equivalents

$53M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$190,936	$239,231	-20.2%
Gross Profit	$41,998	$34,385	+22.1%
Operating Income	-$29M	-$27M	-8.1%
Net Income	-$28M	-$22M	-28.1%